TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | -1 | -2 | -7 | -17 | -8 | 8 | -5 |
| S | %wins | 100 | 80 | 80 | 100 | 80 | 40 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/10 18:42 | 4/1/10 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Batlin Judy A | CA | O | VP,Org L | S.d | -15 | 30.10 | 27 | 0 | -3 | 15 | D | -5 | 6 | 0 | 2 | -1 | -3 | -7 | -3 | -1 | -1 | -3 | -33 | -13 | 17 |
2/9/10 20:16 | 2/8/10 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Batlin Judy A | CA | O | VP,Org L | S | -32 | 28.47 | 22 | -1 | -9 | 11 | D | -37 | -16 | -12 | 7 | -2 | -7 | -2 | -7 | 0 | 4 | 5 | -12 | -3 | 25 |
1/20/10 17:26 | 1/19/10 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Batlin Judy A | CA | O | VP,Org L | S | -22 | 29.96 | 18 | -1 | -6 | 12 | D | -39 | -10 | 8 | 15 | 3 | 4 | 3 | 1 | -2 | -4 | 0 | -1 | -31 | 22 |
2/10/09 14:15 | 2/9/09 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Batlin Judy A | CA | O | VP,Org L | S | -95 | 33.53 | 30 | -3 | -24 | 9 | D | 161 | -29 | -14 | 26 | -2 | 0 | 7 | 2 | -4 | -3 | -20 | -21 | -4 | -11 |
1/23/09 14:45 | 1/21/09 | ONXX | Onyx Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Batlin Judy A | CA | O | VP,Org L | S | -55 | 33.15 | 28 | -2 | -12 | 12 | D | 184 | -28 | -14 | 15 | 10 | -3 | -4 | -2 | 0 | -8 | -16 | -19 | 9 | -11 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |